Military use of drugs not yet approved by the FDA for CW/BW defense : lessons from the Gulf War /

Military use of drugs not yet approved by the FDA for CW/BW defense : lessons from the Gulf War / Richard A. Rettig.

The confrontation that began when Iraq invaded Kuwait in August 1990 brought with it the threat that chemical and biological weapons might be used against the more than half a million military personnel the United States deployed to the region. To protect these troops from such threats, the Departme...

Full description

Saved in:
Bibliographic Details
Online Access: Access E-Book
Access Note:Access to electronic resources restricted to Simmons University students, faculty and staff.
Access limited to one user at a time.
Main Author: Rettig, Richard A.
Corporate Authors: United States. Department of Defense. Office of the Secretary of Defense., National Defense Research Institute (U.S.)
Format: eBook
Language:English
Published: Santa Monica, Calif. : RAND, 1999.
Series:Gulf War illnesses series.
Subjects:
Chemical warfare > Security measures.
Biological warfare > Security measures.
Gases, Asphyxiating and poisonous > Antagonists.
Vaccines.
Informed consent (Medical law) > United States.
Involuntary treatment > United States.
Persian Gulf War, 1991 > Chemical warfare.
United States > Armed Forces > Medical care.

Internet

Access E-Book

Online Resources

Holdings details from Online Resources
Call Number: UG447 .R46 1999eb

Similar Items